This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
Diabetes care, 32(1), 84-90
Citation
Nauck, Michael; Frid, Anders; Hermansen, Kjeld; Shah, Nalini S; Tankova, Tsvetalina; Mitha, Ismail H; Zdravkovic, Milan; Düring, Maria; Matthews, David R. (2009). Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.. Diabetes care, 32(1), 84-90. https://doi.org/10.2337/dc08-1355